Hepatocellular carcinoma - Contrast enhancement with Levovist

被引：27

作者：

Choi, BI

Kim, AY

Lee, JY

Kim, KW

Lee, KH

Kim, TK

Han, JK

机构：

[1] Seoul Natl Univ Hosp, Dept Radiol, Chongno Gu, Seoul 110744, South Korea

[2] Seoul Natl Univ Hosp, Seoul Natl Univ Coll Med, Inst Radiat Med, Seoul, South Korea

[3] Seoul Natl Univ Hosp, Seoul Natl Univ Coll Med, Clin Res Inst, Seoul, South Korea

[4] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Ulsan, South Korea

[5] Hallym Univ Hosp, Dept Radiol, Seoul, South Korea

来源：

JOURNAL OF ULTRASOUND IN MEDICINE | 2002年 / 21卷 / 01期

关键词：

hepatocellular carcinoma; tumor vascularity; Doppler sonography; sonographic contrast agents;

D O I：

10.7863/jum.2002.21.1.77

中图分类号：

O42 [声学];

学科分类号：

070206 ; 082403 ;

摘要：

Objective. To present the sonographic appearance of hepatocellular carcinoma imaged with the intravenous contrast agent Levovist. Methods. We reviewed our experience using Levovist (Schering AG, Berlin, Germany) for the sonographic diagnosis of hepatocellular carcinoma. Results. Contrast-enhanced sonography with Levovist facilitated detailed evaluation of tumor vascularity in hepatocellular carcinoma. Conclusions. Contrast-enhanced sonography with Levovist enhances the role of sonography in the diagnosis of hepatocellular carcinoma. It provides detailed information about tumor vascularity and the contrast enhancement pattern.

引用

页码：77 / 84

页数：8

共 12 条

[1] Hepatocellular carcinoma: Evaluation with biphasic, contrast-enhanced, helical CT [J].